NasdaqCM - Delayed Quote USD

Affimed N.V. (AFMD)

5.03 +0.15 (+3.07%)
At close: April 26 at 4:00 PM EDT
5.03 0.00 (0.00%)
After hours: April 26 at 7:08 PM EDT
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
8,275.00
8,275.00
41,353.00
40,366.00
28,360.00
Operating Expense
119,413.00
119,413.00
130,326.00
105,362.00
63,356.00
Operating Income
-111,138.00
-111,138.00
-88,973.00
-64,996.00
-34,996.00
Net Non Operating Interest Income Expense
238.00
238.00
-1,269.00
-1,127.00
46.00
Other Income Expense
4,965.00
4,965.00
4,240.00
8,602.00
-6,415.00
Pretax Income
-105,935.00
-105,935.00
-86,002.00
-57,521.00
-41,365.00
Tax Provision
3.00
3.00
2.00
2.00
1.00
Net Income Common Stockholders
-105,938.00
-105,938.00
-86,004.00
-57,523.00
-41,366.00
Diluted NI Available to Com Stockholders
-105,938.00
-105,938.00
-86,004.00
-57,523.00
-41,366.00
Basic EPS
-70.90
--
-60.40
-48.10
-5.00
Diluted EPS
-70.90
--
-60.40
-48.10
-5.00
Basic Average Shares
1,493.99
--
1,423.62
1,195.02
8,347.16
Diluted Average Shares
1,493.99
--
1,423.62
1,195.02
8,347.16
Total Operating Income as Reported
-106,661.00
-106,661.00
-88,119.00
-64,030.00
-34,718.00
Total Expenses
119,413.00
119,413.00
130,326.00
105,362.00
63,356.00
Net Income from Continuing & Discontinued Operation
-105,938.00
-105,938.00
-86,004.00
-57,523.00
-41,366.00
Normalized Income
-107,067.70
-107,067.70
-88,600.73
-63,188.53
-36,574.28
Interest Income
509.00
509.00
--
--
186.00
Interest Expense
1,806.00
1,806.00
1,630.00
712.00
95.00
Net Interest Income
238.00
238.00
-1,269.00
-1,127.00
46.00
EBIT
-104,129.00
-104,129.00
-84,372.00
-56,809.00
-41,270.00
EBITDA
-102,380.00
-102,380.00
-81,473.00
-55,475.00
-40,155.00
Reconciled Depreciation
1,749.00
1,749.00
2,899.00
1,334.00
1,115.00
Net Income from Continuing Operation Net Minority Interest
-105,938.00
-105,938.00
-86,004.00
-57,523.00
-41,366.00
Total Unusual Items Excluding Goodwill
1,430.00
1,430.00
3,287.00
7,761.00
-6,564.00
Total Unusual Items
1,430.00
1,430.00
3,287.00
7,761.00
-6,564.00
Normalized EBITDA
-103,810.00
-103,810.00
-84,760.00
-63,236.00
-33,591.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
300.30
300.30
690.27
2,095.47
-1,772.28
12/31/2020 - 9/12/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ADAP Adaptimmune Therapeutics plc
1.0750
+1.42%
 
LPTX Leap Therapeutics, Inc.
3.2500
+2.52%
 
CLRB Cellectar Biosciences, Inc.
3.0300
+0.33%
 
PRQR ProQR Therapeutics N.V.
1.9400
-1.02%
 
MDNAF Medicenna Therapeutics Corp.
1.8200
+30.00%
 
CTMX CytomX Therapeutics, Inc.
1.5900
-0.62%
 
MREO Mereo BioPharma Group plc
2.7400
-2.49%
 
ACET Adicet Bio, Inc.
1.6800
-7.18%
 
LVTX LAVA Therapeutics N.V.
2.7300
+3.41%
 
SPRO Spero Therapeutics, Inc.
1.4600
+2.10%